68Ga-cPP-BCH

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name68Ga-cPP-BCH
Drug Alias NamePD-L1 targeting peptide probe (Peking University Cancer Hospital & Institute)68Ga-cPP-BCH
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPositron-emission tomography enhancersProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumoursLung NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Cancer Hospital
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A